Cargando…

A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children

The low incidence of pediatric severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and the associated multisystem inflammatory syndrome (MIS-C) lack a unifying pathophysiological explanation, impeding effective prevention and therapy. Activation of the NACHT, LRR, and PYD domains-...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadopoulos, Konstantinos I., Papadopoulou, Alexandra, Aw, Tar-Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618415/
https://www.ncbi.nlm.nih.gov/pubmed/36310304
http://dx.doi.org/10.1007/s13577-022-00819-w
_version_ 1784821043768066048
author Papadopoulos, Konstantinos I.
Papadopoulou, Alexandra
Aw, Tar-Choon
author_facet Papadopoulos, Konstantinos I.
Papadopoulou, Alexandra
Aw, Tar-Choon
author_sort Papadopoulos, Konstantinos I.
collection PubMed
description The low incidence of pediatric severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and the associated multisystem inflammatory syndrome (MIS-C) lack a unifying pathophysiological explanation, impeding effective prevention and therapy. Activation of the NACHT, LRR, and PYD domains-containing protein (NLRP) 3 inflammasome in SARS-CoV-2 with perturbed regulation in MIS-C, has been reported. We posit that, early age physiological states and genetic determinants, such as certain polymorphisms of renin-angiotensin aldosterone system (RAAS) molecules, promote a controlled RAAS hyperactive state, and form an evolutionary landscape involving an age-dependent erythropoietin (EPO) elevation, mediating ancestral innate immune defenses that, through appropriate NLRP3 regulation, mitigate tissue injury and pathogen invasion. SARS-CoV-2-induced downregulation of angiotensin-converting enzyme (ACE)2 expression in endothelial cells (EC), impairment of endothelial nitric oxide (NO) synthase (eNOS) activity and downstream NO bioavailability, may promote a hyperactive RAAS with elevated angiotensin II and aldosterone that, can trigger, and accelerate NLRP3 inflammasome activation, while EPO-eNOS/NO abrogate it. Young age and a protective EPO evolutionary landscape may successfully inhibit SARS-CoV-2 and contain NLRP3 inflammasome activation. By contrast, increasing age and falling EPO levels, in genetically susceptible children with adverse genetic variants and co-morbidities, may lead to unopposed RAAS hyperactivity, NLRP3 inflammasome dysregulation, severe endotheliitis with pyroptotic cytokine storm, and development of autoantibodies, as already described in MIS-C. Our haplotype estimates, predicted from allele frequencies in population databases, are in concordance with MIS-C incidence reports in Europeans but indicate lower risks for Asians and African Americans. Targeted Mendelian approaches dissecting the influence of relevant genetic variants are needed.
format Online
Article
Text
id pubmed-9618415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-96184152022-10-31 A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children Papadopoulos, Konstantinos I. Papadopoulou, Alexandra Aw, Tar-Choon Hum Cell Review Article The low incidence of pediatric severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and the associated multisystem inflammatory syndrome (MIS-C) lack a unifying pathophysiological explanation, impeding effective prevention and therapy. Activation of the NACHT, LRR, and PYD domains-containing protein (NLRP) 3 inflammasome in SARS-CoV-2 with perturbed regulation in MIS-C, has been reported. We posit that, early age physiological states and genetic determinants, such as certain polymorphisms of renin-angiotensin aldosterone system (RAAS) molecules, promote a controlled RAAS hyperactive state, and form an evolutionary landscape involving an age-dependent erythropoietin (EPO) elevation, mediating ancestral innate immune defenses that, through appropriate NLRP3 regulation, mitigate tissue injury and pathogen invasion. SARS-CoV-2-induced downregulation of angiotensin-converting enzyme (ACE)2 expression in endothelial cells (EC), impairment of endothelial nitric oxide (NO) synthase (eNOS) activity and downstream NO bioavailability, may promote a hyperactive RAAS with elevated angiotensin II and aldosterone that, can trigger, and accelerate NLRP3 inflammasome activation, while EPO-eNOS/NO abrogate it. Young age and a protective EPO evolutionary landscape may successfully inhibit SARS-CoV-2 and contain NLRP3 inflammasome activation. By contrast, increasing age and falling EPO levels, in genetically susceptible children with adverse genetic variants and co-morbidities, may lead to unopposed RAAS hyperactivity, NLRP3 inflammasome dysregulation, severe endotheliitis with pyroptotic cytokine storm, and development of autoantibodies, as already described in MIS-C. Our haplotype estimates, predicted from allele frequencies in population databases, are in concordance with MIS-C incidence reports in Europeans but indicate lower risks for Asians and African Americans. Targeted Mendelian approaches dissecting the influence of relevant genetic variants are needed. Springer Nature Singapore 2022-10-31 2023 /pmc/articles/PMC9618415/ /pubmed/36310304 http://dx.doi.org/10.1007/s13577-022-00819-w Text en © The Author(s) under exclusive licence to Japan Human Cell Society 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Papadopoulos, Konstantinos I.
Papadopoulou, Alexandra
Aw, Tar-Choon
A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title_full A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title_fullStr A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title_full_unstemmed A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title_short A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
title_sort protective erythropoietin evolutionary landscape, nlrp3 inflammasome regulation, and multisystem inflammatory syndrome in children
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618415/
https://www.ncbi.nlm.nih.gov/pubmed/36310304
http://dx.doi.org/10.1007/s13577-022-00819-w
work_keys_str_mv AT papadopouloskonstantinosi aprotectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren
AT papadopouloualexandra aprotectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren
AT awtarchoon aprotectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren
AT papadopouloskonstantinosi protectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren
AT papadopouloualexandra protectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren
AT awtarchoon protectiveerythropoietinevolutionarylandscapenlrp3inflammasomeregulationandmultisysteminflammatorysyndromeinchildren